PLYMOUTH, Minn., Nov. 19, 2015 (GLOBE NEWSWIRE) -- Entellus Medical, Inc. (NASDAQ:ENTL), a medical technology company focused on delivering superior patient and physician experiences through products designed for the minimally invasive treatment of chronic and recurrent sinusitis patients, today announced the signing of a strategic marketing agreement with Xoran Technologies, LLC, a market leader in medical office-based CT scanning products. The five year agreement between the two companies enables cross-promotion and co-marketing of each company's products as well as collaboration at key industry events.
Xoran's MiniCAT CT scanner is a market leader in office-based CT scanning technology. The CT scan is an integral part of the diagnosis and treatment of patients suffering from sinusitis. It is also a necessary precursor to balloon sinus dilation and advanced sinus procedures. By offering patients immediate and accurate diagnostic information with low-radiation dose technology, the Xoran MiniCAT CT scanner enables ENT clinicians to create a more convenient and safer patient experience. In addition, the Xoran MiniCAT is well-suited for integration and support of the Fiagon Navigation system, for which Entellus is the exclusive distributor to ENT offices and ENT ambulatory surgery centers in the United States.
"Entellus and Xoran are both enabling and empowering ENT physicians to do more for patients within the confines of their office," said Robert White, President and Chief Executive Officer of Entellus Medical. "I am excited to take our efforts to the next level with this long term agreement, the real beneficiaries of which are the physicians and patients who can enjoy the benefits of treatment in the office. We believe this partnership further cements us as a leader in office-based resources and procedural expertise."
"Xoran strives to employ point-of-care imaging to increase the efficiency and quality of healthcare, and the agreement with Entellus will allow us to strengthen that vision," stated David Sarment, DDS, MS, President of Xoran Technologies. "When you combine the efforts of two companies with highly-complimentary products, the value created for both the clinician practices and the patient is evident. We are very excited about this opportunity."
About Entellus Medical, Inc.
Entellus Medical is a medical technology company focused on delivering superior patient and physician experiences through products designed for the minimally invasive treatment of chronic and recurrent sinusitis patients. The Entellus Medical platform of products provides physicians with solutions to aid in the diagnosis and treatment of patients suffering from chronic sinusitis. Its XprESS family of products is used by ENT physicians to open narrowed or obstructed sinus drainage pathways using balloon sinus dilation. When used as a stand-alone therapy, Entellus Medical's balloon sinus dilation products are the only devices proven in a sufficiently powered prospective, multicenter, randomized, controlled trial to be as effective as functional endoscopic sinus surgery ("FESS"). Patients treated with Entellus Medical's products in this trial in the ENT physician's office also experienced faster recovery, less bleeding at discharge, less use of prescription pain medication and fewer post-procedure debridements than patients receiving FESS. In addition to its XprESS line of products, Entellus Medical has recently introduced additional products designed to aid in the diagnosis, treatment and post-operative care of patients suffering from chronic sinusitis.
Entellus Medical currently markets its products in the United States, Europe and Canada and sells its products through a direct sales force in the United States and the United Kingdom. For more information, please visit the Company's website at www.entellusmedical.com.
About Xoran Technologies
Xoran's vision is to improve patient care by delivering innovative CT imaging solutions for instant diagnosis at the patients' point of care. Its core competencies are customer service, medical imaging, and information technologies. Xoran leverages these competencies to produce high quality, safe, effective products and services that meet or exceed its customer's expectations and comply with industry standards and regulations. Its product line consists of the MiniCAT in-office CT scanner, the xCAT mobile CT scanner, and XoranConnect, a web-based medical image viewing and archival tool. All of Xoran's products were designed to eliminate waste and inefficiency in healthcare.
All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on the current expectations of Entellus Medical's management and involve known and unknown risks and uncertainties that may cause Entellus Medical's actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Such risks and uncertainties include, among others, the benefits Entellus Medical expects to achieve as a result of its marketing agreement with Xoran. Other factors that could cause actual results to differ materially from those contemplated in this press release can be found under the caption "Risk Factors" in Entellus Medical's Annual Report on Form 10-K for the fiscal year ended December 31, 2014 filed with the Securities and Exchange Commission ("SEC") and its other reports filed with the SEC. Entellus Medical undertakes no obligation to update or revise any forward looking statements, even if subsequent events cause its views to change.
CONTACT: Leigh Salvo 415-513-1281 email@example.comSource:Entellus Medical, Inc.